Neuropsicofarmacología molecular
Pfizer (United States)
Nueva York, Estados UnidosPfizer (United States)-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2015
-
Inflammation in schizophrenia: A question of balance
Neuroscience and Biobehavioral Reviews, Vol. 55, pp. 612-626